When to Treat Hypertriglyceridemia
Treatment for hypertriglyceridemia should be initiated at ≥500 mg/dL to prevent pancreatitis, while levels between 175-499 mg/dL warrant lifestyle interventions and treatment of secondary factors. 1, 2
Classification and Treatment Thresholds
Severe Hypertriglyceridemia (≥500 mg/dL)
- Primary goal: Reduce triglyceride levels below 500 mg/dL to prevent acute pancreatitis 2
- Requires immediate pharmacologic intervention along with lifestyle changes
- Evaluate for secondary causes of hypertriglyceridemia 1
- First-line medication: Fibrates (fenofibrate 54-160 mg daily) providing 35-50% reduction in triglycerides 2
- Alternative options: Prescription omega-3 fatty acids (4g/day) with 25-35% reduction 2
- For levels ≥1,000 mg/dL, more aggressive dietary measures are needed:
Moderate Hypertriglyceridemia (175-499 mg/dL)
- Address and treat:
- Lifestyle factors (obesity and metabolic syndrome)
- Secondary factors (diabetes, chronic liver or kidney disease, hypothyroidism)
- Medications that raise triglycerides 1
- Individualize fat intake to 20-25% of calories
- Reduce refined carbohydrates 2
- If 10-year ASCVD risk is ≥7.5%, consider moderate-intensity statin therapy 1
- For patients with ASCVD or other cardiovascular risk factors on a statin with controlled LDL but elevated triglycerides (135-499 mg/dL), consider adding icosapent ethyl 1
Borderline Hypertriglyceridemia (150-174 mg/dL)
- Focus on therapeutic lifestyle changes
- Monitor and reassess cardiovascular risk
- No specific pharmacologic therapy recommended unless other lipid abnormalities are present 2
Lifestyle Modifications (First-Line for All Levels)
- Weight reduction (target 5-10% for overweight/obese patients) 2
- Physical activity: At least 150 minutes/week of moderate-intensity exercise 2
- Dietary modifications:
- Complete abstinence from alcohol for those with genetic hypertriglyceridemia 2
Monitoring and Follow-up
- Check triglyceride response after 8-12 weeks of therapy 2
- Monitor for potential increases in LDL-C levels with some treatments 2
- Regular liver and renal function tests with pharmacological therapy, especially with fibrates 2
- Final treatment goal: Reduce triglycerides to <150 mg/dL 2
Special Considerations
- In patients with diabetes, effective insulin therapy and glycemic control are crucial first steps 2
- For patients with acute pancreatitis due to severe hypertriglyceridemia, IV insulin infusion can rapidly lower triglyceride levels 3
- Statins are contraindicated in pregnancy; women of childbearing age should use reliable contraception 2
- In patients with established cardiovascular disease, treatment goals should focus first on LDL-C reduction, followed by non-HDL-C goals 4
Common Pitfalls to Avoid
- Focusing only on triglyceride levels without addressing overall cardiovascular risk
- Neglecting to screen for and treat secondary causes of hypertriglyceridemia
- Using combination therapy (statin plus fibrate) without careful monitoring for myopathy
- Overlooking the importance of lifestyle modifications, which can reduce triglycerides by 20-50%
- Failing to recognize that statin plus niacin combination therapy has not shown additional cardiovascular benefit and may increase stroke risk 1